AFJK Aimei Health Technology Co., Ltd logo

AFJK Aimei Health Technology Co., Ltd

Financial Services
$40.06-1.35%ClosedMarket Cap: $245.2M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

243.87

PEG

P/B

20.16

P/S

0.00

EV/EBITDA

-295.85

DCF Value

$-0.50

FCF Yield

-0.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3.2%

ROA

8.8%

ROIC

-7.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 null$0.00$98.1K$
FY null$0.00$1.1M$
Q3 null$0.00$352.0K$
Q2 null$0.00$425.0K$

Trading Activity

Insider Trades

View All
MIZUHO SECURITIES USA LLC10 percent owner
SellTue Feb 11
MIZUHO SECURITIES USA LLC10 percent owner
SellTue Feb 11

Company Info

Sector

Financial Services

Industry

Shell Companies

Country

US

Exchange

Beta

0.46

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Peers